Cannabis Science Inc. Cannabis Science Inc.
Cannabis Science Inc. Cannabis Science Inc.
  • Home
  • About Us
    • Corporate Overview
    • Mission Statement
    • Cannabis Science Team
    • Careers & Corporate Culture
  • iCannabinoid
    • Join Now!
  • R&D
    • The Science of Cannabinoids
    • CBIS Cannabinoid Research
    • Critical Ailments
  • COLLABORATIONS & PROJECTS
    • CBIS Medical Consortium
    • Global Economic Development
    • Pan African A & C University
    •     African Economic Initiative
    • American States University
    •     North American Economic Initiative
    • Dana-Farber
    • CFA
    • Stellenbosch University
    • CBIS Bottle It
  • Products & Pharmacies
    • Products
    • Order Online
    • Pharmacies
  • Investors
    • CBIS Current Share Structure
    • SEC Filings
  • Media
    • CBIS News Releases
    • CBIS In The News
    • CBIS Events
  • Contact

latest Articles

  • Cannabis Science Issues 2019 Guidance Report; Under SEC Sanctions the Company Goes Private as It Enters Into Step (2) of Its Growth Transition, Enabling Full Transparency and Revenue Growth
  • Cannabis Science Enters Transition Stage as Trading of the Company’s Shares is Halted; The Company Will Continue to Implement Its Growth Strategy and Resolve All Outstanding Fully Reporting Requirements
  • Cannabis Science Partners With CDN Firm NHS Industries to Launch the CBIS CDN Economic Development Plan; CBIS to Use Its Relations With the Harvard International Phytomedicines and Medical Cannabis Institute and Other Leading Institutions
  • Cannabis Science Prepares Announcements for Revenues and Corporate Growth; Finalizing New Asset Partnerships and Acquisitions Targeting Positive Cash Flow in Key Markets Globally
  • Cannabis Science Successfully Completes European Headquarters and Operations Move to The Netherlands and Completes Shut Down of All Cannabis Science Europe GmbH Germany Operations

  1. Home

Total: 448 results found.

Page 2 of 23

Cannabis Science Expands Into Canadian Market With Wholly-Owned Subsidiary Cannabis Science Canada Inc., Commences Negotiations for Canadian Land, Licenses, and Expansion Capital

Created on 2019-03-25 10:37:00

Cannabis Science iCannabinoid Ambassadors Program Appointments Underway; Ambassadors Will Promote Company Initiatives Globally and Help Share Accurate and Reliable Health Information

Created on 2019-03-15 10:37:00

Cannabis Science Set to Integrate Its Sponsored Research In Nigeria to Include Its U.S. Patent Number 9,763,991 for Compositions of Cannabinol (CBN) for Treatment of Various Neurological Conditions

Created on 2019-02-25 10:37:00

Cannabis Science Receives Tremendous Response for CEO’s Personal Shareholder Loyalty Gift; Planning Underway for the Company’s 2019 Black-Tie Dinner Awards Gala Presentations

Created on 2019-02-08 10:37:00

Cannabis Science Receives Overwhelming Response From Mr. Raymond C. Dabney’s Shareholder Loyalty Gift Package; Get Set for Cannabis Science 2019 Black-Tie Dinner Awards Gala

Created on 2019-01-15 10:37:00

CBIS Celebrates U.S. Congress Passage of the 2018 Farm Bill and RCD Welcomes All Shareholders to the Loyalty Gift Final

Created on 2018-12-24 10:37:00

The Cannabis Science Inaugural Black-Tie Dinner Awards Gala Final Planning Underway; Recognizing Major Industry Accomplishments, Killing Cancer, and Awarding Unprecedented Shareholder Loyalty

Created on 2018-11-21 10:37:10

Cannabis Science Confirms Receipt of Issued US Patent Number 9,763,991 For Compositions of Cannabinol (CBN) for Treatment of Various Neurobehavioral Disorders, Sleep Deprivation (Insomnia), Anxiety Disorders (ADHD), and (PTSD)

Created on 2018-10-29 18:17:15

CBIS Re-Appoints Mr. Melvin Foote to Its International Government Affairs Board; Mr. Foote Will Continue to Counsel CBIS as South African Cannabinoid Clinical Studies are Underway

Created on 2018-10-24 10:08:25

Cannabis Science, Inc. Appoints Dr. Joe Wilson, an Information Technology and Risk Management Expert, to Its International Government Affairs Board (IGAB)

Created on 2018-10-01 20:49:43

Dr. Joe Wilson

Created on 2018-09-28 00:07:56

Cannabis Science, Inc. Re-Appoints Dr. Brylyne Chitsunge, Pan-African Ambassador for Food Security, and Ms. Julia Royall, Global Health Information Specialist, to Its Revamped Scientific Advisory Board

Created on 2018-09-26 17:50:59

Cannabis Science, Inc. Appoints Dr. Jermane Bond, Noted Research Scientist, to Its Scientific Advisory Board

Created on 2018-09-21 18:22:36

Dr. Jermane Bond (2)

Created on 2018-09-21 06:27:12

Dr. Jermane Bond

Created on 2018-09-21 06:27:12

Cannabis Science Launches New Corporate Advisory Structure; Appoints Presidents for Its Scientific Advisory and International Government Affairs Advisory Boards

Created on 2018-09-13 17:03:18

Cannabis Science Invited to Deliver Keynote Address at European Summit Organized by The University of Heidelberg and Harvard Medical School’s Global Health Catalyst

Created on 2018-08-31 18:25:30

Global Health Catalyst Europe Summit 2018.

Created on 2018-08-31 16:44:47

Cannabis Science Launches Its New Corporate Website

Created on 2018-08-21 15:59:00

Cannabis Science, Inc. Announces New Company Website, New Management Team Expansions, & Pushes to Complete Updated Financial Reporting Requirements

Created on 2018-08-14 15:59:36

  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • End
REACH US.

2019 US Federal Contractor

DUNS number: 830406356
CAGE code: 5FZM9

NAICS Codes selected:

541711 - Research and Development in Biotechnology

621511 - Medical Laboratories

624230 - Emergency And Other Relief Services

Contact.

Cannabis Science Inc.

Mr. Raymond C. Dabney
President & CEO

raymond.dabney@cannabisscience.com



 
 
Copyright © 2019 Cannabis Science Inc. All Rights Reserved.